Concomitantly, Nfe2 shRNA transduction significantly reduced the tumor growth of 4T1.3 and TS/A.3 clones upon their intraosseous injection (Figure 4f) with few effects on their tumor formation upon their injection into mammary fat pads (Figure 4g). The gene discussed is NFE2; the disease is neoplasm.